IP Library › Granted Patent US 10,190,135
Granted Patent B2
US 10,190,135 · App. 15/335,930 · Granted Jan 29, 2019

Chimeric post-transcriptional regulatory element

Inventors: Nikhil Goel (Union City, CA); Amita Goel (Union City, CA)
Assignee: Celltheon Corporation
C12N15/85C07K16/2887C12N2800/107C12N2830/30C12N2830/48C12N2830/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,190,135
App. No.
15/335,930
Granted
Jan 29, 2019
Kind
B2
Abstract

The present disclosure relates to chimeric post-transcriptional regulatory elements (PRE) and vectors useful for expressing a protein in a cell. The PRE contains alpha, beta and optionally gamma subelements selected from different native PRE sequences and are discovered to be more potent than their native counterparts.

Claims (9)

1. A polynucleotide comprising:

(a) a first fragment consisting of the nucleic acid sequence of SEQ ID NO: 7 or a nucleic acid sequence having at least 95% sequence identity to SEQ ID NO: 7,

(b) a second fragment consisting of the nucleic acid sequence of SEQ ID NO: 9 or a nucleic acid sequence having at least 95% sequence identity to SEQ ID NO: 9, and

(c) a third fragment consisting of the nucleic acid sequence of SEQ ID NO: 3 or a nucleic acid sequence having at least 95% sequence identity to SEQ ID NO: 3.

2. The polynucleotide of claim 1 , wherein the second fragment is between the first fragment and the third fragment and each fragment is not more than 20 nucleotides away from a neighboring fragment.

3. A polynucleotide construct, comprising the polynucleotide of claim 1 and a protein-coding sequence.

4. The polynucleotide construct of claim 3 , further comprising a 3′-UTR.

5. The polynucleotide construct of claim 3 , further comprising a poly(A) sequence.

6. A cell, in culture, comprising the polynucleotide construct of claim 3 .

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE SECOND INVENTOR'S EXECUTION DATE PREVIOUSLY RECORDED ON REEL 040178 FRAME 0263. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 1, 2016
From: GOEL, NIKHIL; GOEL, AMITA
To: CELLTHEON CORPORATION
Reel/Frame 040961/0538 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2016
From: GOEL, NIKHIL; GOEL, AMITA
To: CELLTHEON CORPORATION
Reel/Frame 040178/0263 →
Continuity (2)
Provisional Application 62246841 · Oct 27, 2015
Related Publication 20170114363A1 · Apr 27, 2017